Cite Filings / FATE / 0001193125-23-110475

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

FATE THERAPEUTICS INC Filed 2023-04-21 Acc 0001193125-23-110475

Documents 1

DEF 14A Proxy Statement , d320713ddef14a.htm

Around this filing

2024-04-26 DEF 14A Proxy Statement
2023-04-21 ARS Annual Report to Security Holders
2023-04-21 DEFA14A Proxy Materials
2023-04-21 DEF 14A Proxy Statement
2023-04-21 4 Director bought 276,639 shares at an average $6.17 ($1,705,829)
2023-04-19 SC 13D/A Beneficial Ownership Report
2022-04-25 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading d320713ddef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…